NO20082439L - Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma - Google Patents

Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma

Info

Publication number
NO20082439L
NO20082439L NO20082439A NO20082439A NO20082439L NO 20082439 L NO20082439 L NO 20082439L NO 20082439 A NO20082439 A NO 20082439A NO 20082439 A NO20082439 A NO 20082439A NO 20082439 L NO20082439 L NO 20082439L
Authority
NO
Norway
Prior art keywords
treatment
tiotropium salts
persistent asthma
moderate persistent
moderate
Prior art date
Application number
NO20082439A
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082439(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20082439L publication Critical patent/NO20082439L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse angår anvendelse av tiotropiumsalter for fremstilling av et medikament for behandling av pasienter som lider av moderat vedvarende astma.
NO20082439A 2006-01-04 2008-05-28 Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma NO20082439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (1)

Publication Number Publication Date
NO20082439L true NO20082439L (no) 2008-08-04

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082439A NO20082439L (no) 2006-01-04 2008-05-28 Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma

Country Status (30)

Country Link
US (2) US20070155773A1 (no)
EP (1) EP1971332B1 (no)
JP (1) JP2009525950A (no)
KR (1) KR20080083060A (no)
CN (1) CN101355937A (no)
AR (1) AR059126A1 (no)
AT (1) ATE500825T1 (no)
AU (1) AU2006334367B2 (no)
BR (1) BRPI0620886A2 (no)
CA (1) CA2634984C (no)
CY (1) CY1111534T1 (no)
DE (1) DE602006020620D1 (no)
DK (1) DK1971332T3 (no)
EA (1) EA015353B1 (no)
EC (1) ECSP088588A (no)
ES (1) ES2362306T3 (no)
HR (1) HRP20110200T1 (no)
IL (1) IL192602A (no)
ME (1) ME01205B (no)
MY (1) MY146362A (no)
NO (1) NO20082439L (no)
NZ (1) NZ570162A (no)
PL (1) PL1971332T3 (no)
PT (1) PT1971332E (no)
RS (1) RS51703B (no)
SI (1) SI1971332T1 (no)
TW (1) TW200731976A (no)
UA (1) UA95271C2 (no)
WO (1) WO2007077162A1 (no)
ZA (1) ZA200804436B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0614394A2 (pt) 2005-08-06 2011-03-29 Boehringer Ingelheim Int uso de sais de tiotrópio
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
BR0114584A (pt) * 2000-10-12 2003-08-26 Boehringer Ingelheim Pharma Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
SI1682542T1 (sl) * 2003-11-03 2010-04-30 Boehringer Ingelheim Int Nov kristaliniŽŤen anhidrat z antiholinergiŽŤno uŽŤinkovitostjo
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
JP5165244B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
AU2006244683A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
AU2006248189A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
BRPI0614394A2 (pt) * 2005-08-06 2011-03-29 Boehringer Ingelheim Int uso de sais de tiotrópio
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
AU2006334367A1 (en) 2007-07-12
ME01205B (me) 2013-03-20
EP1971332A1 (en) 2008-09-24
PL1971332T3 (pl) 2011-08-31
US20070155773A1 (en) 2007-07-05
WO2007077162A1 (en) 2007-07-12
AU2006334367B2 (en) 2012-11-08
CY1111534T1 (el) 2015-08-05
BRPI0620886A2 (pt) 2011-11-29
RS51703B (en) 2011-10-31
SI1971332T1 (sl) 2011-05-31
AR059126A1 (es) 2008-03-12
CA2634984A1 (en) 2007-07-12
KR20080083060A (ko) 2008-09-12
DE602006020620D1 (de) 2011-04-21
ECSP088588A (es) 2008-07-30
EA200801629A1 (ru) 2008-12-30
ZA200804436B (en) 2008-12-31
TW200731976A (en) 2007-09-01
IL192602A (en) 2013-06-27
US20150224090A1 (en) 2015-08-13
HRP20110200T1 (hr) 2011-04-30
ATE500825T1 (de) 2011-03-15
ES2362306T3 (es) 2011-07-01
MY146362A (en) 2012-08-15
EP1971332B1 (en) 2011-03-09
UA95271C2 (ru) 2011-07-25
IL192602A0 (en) 2009-09-22
CN101355937A (zh) 2009-01-28
PT1971332E (pt) 2011-03-18
CA2634984C (en) 2014-05-06
NZ570162A (en) 2011-09-30
DK1971332T3 (da) 2011-04-18
JP2009525950A (ja) 2009-07-16
EA015353B1 (ru) 2011-06-30

Similar Documents

Publication Publication Date Title
DK1765349T3 (da) Opioider til behandling af kronisk obstruktiv lungesygdom
WO2009153665A3 (en) Inhibitors of the shiga toxins trafficking through the retrograde pathway
MX346186B (es) Inhibidores de proteina cinasas.
EA201400591A1 (ru) Ингалятор
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
MX341212B (es) Inhibidor de bromodominio de benzodiazepina.
WO2007144327A3 (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
WO2007048801A3 (en) Sexual desire enhancing medicaments comprising benzimidazolone derivatives
ATE524450T1 (de) 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren
NO20084328L (no) Nye forbindelser
WO2012040636A3 (en) Compounds and methods for treating diseases mediated by protease activated receptors
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
EA201171172A1 (ru) Применение в терапии производных хиназолиндиона
EA201290603A1 (ru) Способ лечения
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
EA201201395A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
EA200900261A1 (ru) Применение эсцина
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
MX2008001506A (es) Uso de sales de triotropio en el tratamiento de asma severa persistente.
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
NZ597359A (en) Emergency interventions of active charcoal with dabigatran etexilate overdosing
WO2011056850A3 (en) Linaclotide for the treatment of chronic constipation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application